Shanghai, China, March 14, 2017 – Broda Technologies Co., Ltd. today announced it has been granted a new US Patent 9,592,295 on March 14 for a patent titled “Reversely Thermal-Reversible Hydrogel Compositions”.
The patent extends the coverage of Company’s key IntelliGel® supramolecular smart drug delivery technology and its application in pharmaceutical, cosmetic and personal care products.
“The granting of a new US patent for the supramolecular smart drug delivery technology broadens our coverage for the technology. IntelliGel supramolecular smart drug delivery system has wide potential applications with enhanced efficacy, patient compliance, and safety compared with existing pharmaceutical and cosmetic products.” stated Broda Technologies’ President Dr. Shao Lu.
About Broda Technologies
Broda Technologies Co. Ltd. is a small technology company focus on supramolecular smart drug delivery technology and the development of related products. The Company’s proprietary IntelliGel® supramolecular smart drug delivery system is capable of dissolving water insoluble or sparely soluble drugs with sustained release in a clear and transparent thermo-responsive hydrogel for enhanced efficacy, safety and patient’s compliance. For more information, please visit www.brodatech.com.
Contact
Broda Technologies Co., Ltd.
Shao Lu, Ph.D.
Tel: +86 21 2022 5388
E-mail: info@brodatech.com
Find out how our breakthrough smart supramolecular drug delivery plateform technology can help you maximizing potential of your development drug and related consumer care products.
Email: